Autoimmune hemolytic anemia epidemiology and demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Assosciate Editor(s)-In-Chief: Prashanth Saddala M.B.B.S; Shyam Patel [2], Irfan Dotani [3]
Overview
Overall, the incidence and prevalence of autoimmune hemolytic anemia are low. This condition affects a very small proportion of the population. Autoimmune hemolytic anemia affects men and women equally. There is no racial predilection for autoimmune hemolytic anemia.
Epidemiology and Demographics
Incidence
- The incidence of autoimmune hemolytic anemia overall is estimated to be between 0.8 in 100,000 and 3 in 100,000 per year.[1][2][3]
- The incidence of warm autoimmune hemolytic anemia is estimated to be between 1.25 in 100,000 and 1.33 in 100,000.[4]
- The incidence of drug-induced hemolytic anemia is 1 in 1,000,000.[4]
Prevalence
- The prevalence of autoimmune hemolytic anemia is 17 in 100,000.[3]
Age
- The incidence of autoimmune hemolytic anemia in children is 0.2 in 100,000.[3]
- The incidence of autoimmune hemolytic anemia is higher in adults that in children.[2]
Race
- Autoimmune hemolytic anemia affects all racial backgrounds equally.
Gender
- Autoimmune hemolytic anemia affects men and women equally.
References
- ↑ Böttiger LE, Westerholm B (1973). “Acquired haemolytic anaemia. I. Incidence and aetiology”. Acta Med Scand. 193 (3): 223–6. PMID 4739592. Unknown parameter
|month=ignored (help) - ↑ 2.0 2.1 Berentsen S (2015). “Role of Complement in Autoimmune Hemolytic Anemia”. Transfus Med Hemother. 42 (5): 303–10. doi:10.1159/000438964. PMC 4678321. PMID 26696798.
- ↑ 3.0 3.1 3.2 Zanella A, Barcellini W (2014). “Treatment of autoimmune hemolytic anemias”. Haematologica. 99 (10): 1547–54. doi:10.3324/haematol.2014.114561. PMC 4181250. PMID 25271314.
- ↑ 4.0 4.1 Packman CH (2015). “The Clinical Pictures of Autoimmune Hemolytic Anemia”. Transfus Med Hemother. 42 (5): 317–24. doi:10.1159/000440656. PMC 4678314. PMID 26696800.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH